Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study

Publication Type:

Journal Article

Source:

Lancet Gastroenterol Hepatol, Volume 5, Issue 7, p.649-657 (2020)
Top